Skip to content

Relationship Between Effect Duration of Rocuronium and Body Composition Analysis Data.

Relationship Between Effect Duration of Rocuronium and Body Composition Analysis Data.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05515835
Enrollment
88
Registered
2022-08-25
Start date
2022-09-05
Completion date
2023-03-31
Last updated
2023-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rocuronium, Body Composition

Brief summary

The induction dose of rocuronium is typically decided based on the patient's body weight, but the effect duration of rocuronium is variable. Some studies suggest that body composition analysis data, such as skeletal muscle mass or total body water, may correlate better with the duration time of rocuronium. Therefore, we plan to analyse body composition in patients undergoing total intravenous general anesthesia, give the patients a fixed dose (50mg) of rocuronium, and check the correlation between duration time of rocuronium and body composition analysis data.

Interventions

Patients will undergo body composition analysis using bioelectical impedance method before anesthesia.

Sponsors

Samsung Medical Center
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients with ASA class I-II undergoing total intravenous general anesthesia

Exclusion criteria

* too overweight (over 111.11kg, which corresponds to less than 0.45mg/kg of induction dose of rocuronium) * too underweight (under 41.67kg, which corresponds to more than 1.2mg/kg of induction dose of rocuronium) * pregnancy * prediagnosed muscle or nerve related disease * unsuitable for body composition analysis using bioelectrical impedance method * unsuitable for neuromuscular block monitoring

Design outcomes

Primary

MeasureTime frameDescription
time to TOF1up to 1 hour after rocuronium administration during induction of anesthesiacorrelation between the time from induction to recovery of 1st TOF twitch and age, sex, ASA class, body weight, and body composition analysis data
time to TOF4up to 1.5 hour after rocuronium administration during induction of anesthesiacorrelation between the time from induction to recovery of 4th TOF twitch and age, sex, ASA class, body weight, and body composition analysis data

Secondary

MeasureTime frameDescription
time to loss of TOFup to 5 minutes after rocuronium administration during induction of anesthesiacorrelation between the time from injection of rocuronium to complete loss of TOF twitch and age, sex, ASA class, body weight, and body composition analysis data

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026